Andere Sprachen Addex Therapeutics Ltd

Aktien

A0MSH6

CH0029850754

ADXN

Verzögert Swiss Exchange Andere Börsenplätze 10:34:19 19.04.2024			% 5 Tage	% 1. Jan.
0,16 ^CHF	+0,31 %		-15,79 %	+247,83 %

18.04.	Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024
18.04.	Addex Therapeutics Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Addex to Present at the Swiss Biotech Day 2024	07:02
Addex to Present at the Swiss Biotech Day 2024	07:00
Addex Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	18.04.
Addex freine ses pertes et se concentre sur sa nouvelle organisation	18.04.
Addex Therapeutics Logs Decline in FY23 Net Loss; Revenue Rises	18.04.
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	18.04.
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	18.04.
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	18.04.
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024	11.04.
ADRs End Higher; Biophytis Climbs 30%	09.04.
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09.04.
Top Premarket Gainers	09.04.
ADRs Advance, Eco Wave Power Global AB Climbs 213.4%	08.04.
Powell Speech Eyed, Intel Weighs on Sentiment as US Equity Futures Waver Premarket	03.04.
Top Premarket Gainers	03.04.
Addex Therapeutics Announces the Launch of Neurosterix, Company Focused on Developing Allosteric Modulators for the Treatment of Underserved Neurological Disorders	03.04.
Addex externalise sa plateforme technologique dans une nouvelle société	03.04.
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	03.04.
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	03.04.
Addex to Present at the Bio-Europe Spring 2024 Conference	14.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Addex Therapeutics Ltd

Aktien

A0MSH6

CH0029850754

ADXN

Andere Sprachen

Filter